Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety.wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
Glaxo Group Limited
A A A C A A C
A61P A61P A61P C07D A61P A61P C04B
inventional inventional inventional inventional inventional inventional inventional
Barbara Jessica Steven Mark Simon Edward Giancarlo Luigi Piero Matteo Antonio Kuok Keong Alessandro Markus Marilisa Colin Philip Domenica Antonia
Bertani Tibasco Bromidge Ward Merlo Stasi Biagetti Vong Falchi Bergauer Rinaldi Leslie Pizzi